Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Clinical Characteristics, Management, and Allogeneic Hematopoietic Cell Transplantation of Patients with Toll-like Receptor 8 Gain-of-Function Mutations

Danielle E Arnold, Saara Kaviany, Jahnavi Aluri, Luis Murguia-Favela, Nicola A. Wright, Thomas P. Loughran, Jr., Jonathan Powell, Suk See De Ravin, V. Koneti Rao, Steven Holland, Jack Bleesing, Jeffrey J. Bednarski, James A. Connelly, Megan Cooper

Blood (2023) 142 (Supplement 1): 936.

https://doi.org/10.1182/blood-2023-185110

Published: 2023

Journal Articles

Lack of an Alberta Newborn Screening Program Is Associated with Delayed Diagnosis of Sickle Cell Disease

Dania Monagel, MDFRCPC,FAAP, Michael Leaker, MDFRCPC, Doan Le, MDFRCPC,FAAP, Nicola A. Wright, MSc, MD FRCPC, Angela Ruzycki, MacGregor Steele, MD FRCPC

Blood (2017) 130 (Supplement 1): 2255.

https://doi.org/10.1182/blood.V130.Suppl_1.2255.2255

Published: 2017

Journal Articles

Allogeneic Transplantation for P40 CGD Is Curative of Inflammatory Disease

Elizabeth M. Kang, MD, Nicola A. Wright, MD FRCPC, Katherine Nicholls, MBBS, FRACP, FRCPA, Dianne Hilligoss, RN, MSN, CRNP, Corin Kelly, RN, Douglas B. Kuhns, PhD, Harry L. Malech, MD

Blood (2015) 126 (23): 5515.

https://doi.org/10.1182/blood.V126.23.5515.5515

Published: 2015

Journal Articles

"Hu thal" : A Survey of North American, Indian and Thai Hematologists Regarding Hydroxyurea Use in Thalassemia

Ravi Shah, MD, Vip Viprakasit, MD D.Phil (Oxon), Amita Trehan, MD, Nicola A. Wright, MD FRCPC

Blood (2014) 124 (21): 4036.

https://doi.org/10.1182/blood.V124.21.4036.4036

Published: 2014

Journal Articles

Hydroxyurea for β-Thalassemia Major: A Meta-Analysis

Ali H. Algiraigri, MBBCh, FRCPC, Nicola A. Wright, MD FRCPC, Aliya Kassam, PhD

Blood (2014) 124 (21): 4894.

https://doi.org/10.1182/blood.V124.21.4894.4894

Published: 2014

Journal Articles

Hydroxyurea for Non-Transfusion-Dependent β-Thalassemias: A Meta-Analysis

Ali H. Algiraigri, MBBCh,FRCPC, Nicola A. Wright, MD FRCPC, Aliya Kassam, PhD

Blood (2014) 124 (21): 4897.

https://doi.org/10.1182/blood.V124.21.4897.4897

Published: 2014

NARROW

Clinical Characteristics, Management, and Allogeneic Hematopoietic Cell Transplantation of Patients with Toll-like Receptor 8 Gain-of-Function Mutations

Lack of an Alberta Newborn Screening Program Is Associated with Delayed Diagnosis of Sickle Cell Disease

Allogeneic Transplantation for P40 CGD Is Curative of Inflammatory Disease

"Hu thal" : A Survey of North American, Indian and Thai Hematologists Regarding Hydroxyurea Use in Thalassemia

Hydroxyurea for β-Thalassemia Major: A Meta-Analysis

Hydroxyurea for Non-Transfusion-Dependent β-Thalassemias: A Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

Clinical Characteristics, Management, and Allogeneic Hematopoietic Cell Transplantation of Patients with Toll-like Receptor 8 Gain-of-Function Mutations

Lack of an Alberta Newborn Screening Program Is Associated with Delayed Diagnosis of Sickle Cell Disease

Allogeneic Transplantation for P40 CGD Is Curative of Inflammatory Disease

"Hu thal" : A Survey of North American, Indian and Thai Hematologists Regarding Hydroxyurea Use in Thalassemia

Hydroxyurea for β-Thalassemia Major: A Meta-Analysis

Hydroxyurea for Non-Transfusion-Dependent β-Thalassemias: A Meta-Analysis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only